The VITAL amyloidosis study: A randomized, double-blind, placebo-controlled, global, phase 3 study of NEOD001 in patients with AL amyloidosis and cardiac dysfunction Meeting Abstract
| Authors: | Liedtke, M.; Merlini, G.; Landau, H.; Comenzo, R. L.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G. G.; Koller, M.; Gertz, M. A. |
| Abstract Title: | The VITAL amyloidosis study: A randomized, double-blind, placebo-controlled, global, phase 3 study of NEOD001 in patients with AL amyloidosis and cardiac dysfunction |
| Meeting Title: | 58th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 128 |
| Issue: | 22 |
| Meeting Dates: | 2016 Dec 3-6 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-12-02 |
| Language: | English |
| ACCESSION: | WOS:000394452705009 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V128.22.5690.5690 |
| Notes: | Meeting Abstract: 5690 -- Source: Wos |
